Ledger.Open graph →
SEC Form D · filed April 14, 2021

Ventus Therapeutics U.S., Inc

Offering
$100.0M
Sold
$100.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Waltham, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Jamie Price · New York, NYExecMarcelo Bigal · Walthum, MAExec · DirectorCharlie K. Wuischpard · Wayne, PADirectorKevin Phillip · Grand Cayman, Cayman IslandsExec · DirectorMatej Moravcik · Selce, 2BExecJerel Davis · Walthum, MADirectorNicholas C. Stacey · Denver, COExecJack K. Eadie · Wayne, PADirectorJosh Resnick · Walthum, MADirectorJon Frojen · New York, NYExec · DirectorIvana Faltysova · Grand Cayman, Cayman IslandsExecRudolf Kadlec · Zvole u Prahy, 2NDirectorMilton R. Berlinski · New York, NYExecDaniel Koerwer · Walthum, MAExecValerie Brown · New York, NYDirectorMatthew Snyder · ARMONK, NYDirectorVladimir K. Tamarkin · Wayne, PADirectorMartin Schmid · Stare Hradiste, 2NDirectorBrendan Bulik-Sullivan · Walthum, MADirectorGunnar K. Gunnarsson · Wayne, PAExecZachary Mcnealy · Walthum, MAExecMichael Crackower · Waltham, MAExecAndrej Kiska · Luxembourg-Findel, LuxembourgDirectorSteven James · Walthum, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗